Johnson & Johnson Cardiovascular & Metabolism News and Activities

Johnson & Johnson Cardiovascular & Metabolism is owned by Johnson & Johnson.

Johnson & Johnson is one of the...

• Forbes Global 2000 (#42);
• Fortune 500 (#42);
• Global Fortune 500 (#131);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Johnson & Johnson is a company listed under the stock ticker JNJ (US).

Johnson & Johnson has a direct presence in 23 countries.

Johnson & Johnson has 56 subsidiaries including Abiomed, DePuy Synthes and Ethicon.

They are in:

• Pharmaceuticals61%
• Medical Equipment19%
• Other19%

Acquisition, funding and merger involving Johnson & Johnson.

• Johnson & Johnson has announced the acquisition of Intra-Cellular Therapies  (posted on January 13 2025).
• Johnson & Johnson has acquired V-Wave (posted on October 9 2024).
• Johnson & Johnson has announced the acquisition of Proteologix  (posted on June 21 2024).

View the org chart displaying its 7 main executives

Most searched biographies at Johnson & Johnson Cardiovascular & Metabolism

• Sonal Patel, Vice President, Business Development, Cardiovascular
• Michael Genus, Vice President, Business Development, Cardiovascula...
• Frank Demiro, Director, Healthcare Policy and Strategy

Popular executive movements at Johnson & Johnson Cardiovascular & Metabolism

• Sonal Patel has joined the company as Vice President, Business Development, Cardiovascular  (posted on March 26 2026).

Popular executive movements at Johnson & Johnson

• Ryan Koors will join the company as Vice President, Investor Relations on May 6, 2026  (posted on April 30 2026).
• Lauren Johnson, who was Senior Director, Investor Relations, is promoted to Chief Financial Officer, External Innovation Finance  (posted on February 26 2026).
• Geetanjali Gamel, who was Head of Human Resources, Global Commercial Strategy and Business Development, is promoted to Head of Human Resources, US Surgery  (posted on January 5 2026).

Click here to view some more movements at Johnson & Johnson

Create your alert
to follow the executive moves at Johnson & Johnson Cardiovascular & Metabolism.

Johnson & Johnson has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Corden Pharma has announced the acquisition of AmbioPharm  (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Johnson & Johnson Cardiovascular & Metabolism

Social media about Johnson & Johnson Cardiovascular & Metabolism

• Johnson & Johnson Cardiovascular & Metabolism on Wikipedia, Google News & Yahoo Finance
• Johnson & Johnson Cardiovascular & Metabolism on LinkedIn, X (Twitter) & YouTube